Viewing Study NCT03830866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2026-02-20 @ 12:46 PM
Study NCT ID: NCT03830866
Status: COMPLETED
Last Update Posted: 2024-07-26
First Post: 2018-12-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Durvalumab View
None Chemoradiotherapy View
None Locally Advanced Cervical Cancer View